Back to Search
MAE KUNG, PHARMD
PHARMD
Pharmacist
NPI: 1619091618Individual
Specialties, Licenses & Credentials
PharmacistPrimary
Pharmacist
Code: 183500000X
Research & Publications (20)
In vivo imaging of beta-cell mass in rats using 18F-FP-(+)-DTBZ: a potential PET ligand for studying diabetes mellitus.
PMID 18552132·J Nucl Med·2008
7-preclinical
Characterization of optically resolved 9-fluoropropyl-dihydrotetrabenazine as a potential PET imaging agent targeting vesicular monoamine transporters.
PMID 17383573·Nucl Med Biol·2007
7-preclinical
Mass effect of injected dose in small rodent imaging by SPECT and PET.
PMID 16243641·Nucl Med Biol·2005
6-review
Selective binding of 2-[125I]iodo-nisoxetine to norepinephrine transporters in the brain.
PMID 15219270·Nucl Med Biol·2004
7-preclinical
Binding of two potential imaging agents targeting amyloid plaques in postmortem brain tissues of patients with Alzheimer's disease.
PMID 15464749·Brain Res·2004
4-observational
Characterization of IMPY as a potential imaging agent for beta-amyloid plaques in double transgenic PSAPP mice.
PMID 15007564·Eur J Nucl Med Mol Imaging·2004
7-preclinical
Development and evaluation of iodinated tracers targeting amyloid plaques for SPECT imaging.
PMID 15314249·J Mol Neurosci·2004
6-review
Characterization of radioiodinated ligand binding to amyloid beta plaques.
PMID 14501004·J Mol Neurosci·2003
7-preclinical
Detection of amyloid plaques by radioligands for Abeta40 and Abeta42: potential imaging agents in Alzheimer's patients.
PMID 12663930·J Mol Neurosci·2003
7-preclinical
IMPY: an improved thioflavin-T derivative for in vivo labeling of beta-amyloid plaques.
PMID 12445687·Brain Res·2002
7-preclinical
Comparing the scoring mechanisms of p16INK4a immunohistochemistry based on independent nucleic stains and independent cytoplasmic stains in distinguishing between endocervical and endometrial adenocarcinomas in a tissue microarray study.
PMID 19418062·Arch Gynecol Obstet·2010
4-observational
Validation of an (18)F-labeled biphenylalkyne as a positron emission tomography imaging agent for beta-amyloid plaques.
PMID 19423009·Nucl Med Biol·2009
4-observational
Ancillary p16(INK4a) adds no meaningful value to the performance of ER/PR/Vim/CEA panel in distinguishing between primary endocervical and endometrial adenocarcinomas in a tissue microarray study.
PMID 19153755·Arch Gynecol Obstet·2009
8-other
Magnitude of QT prolongation associated with a higher risk of Torsades de Pointes.
PMID 19145580·Pharmacoepidemiol Drug Saf·2009
8-other
Iodophenyl tagged sphingosine derivatives: synthesis and preliminary biological evaluation.
PMID 19467599·Bioorg Med Chem Lett·2009
8-other
Neuromyelitis optica-IgG in idiopathic inflammatory demyelinating disorders amongst Hong Kong Chinese.
PMID 19138340·Eur J Neurol·2009
8-other
Mitochondrial UCP4 attenuates MPP+ - and dopamine-induced oxidative stress, mitochondrial depolarization, and ATP deficiency in neurons and is interlinked with UCP2 expression.
PMID 19150400·Free Radic Biol Med·2009
7-preclinical
Synthesis of Fluorescent Probes based on Stilbenes and Diphenylacetylenes targeting β-Amyloid Plaques.
PMID 19122762·Tetrahedron Lett·2008
8-other
In vivo imaging of vesicular monoamine transporter 2 in pancreas using an (18)F epoxide derivative of tetrabenazine.
PMID 19026944·Nucl Med Biol·2008
7-preclinical
Striking confinement effect: AuCl4(-) binding to amines in a nanocage cavity.
PMID 19006309·J Am Chem Soc·2008
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1340 S CANAL ST
CHICAGO, IL 60607 - Phone
- (312) 850-0398
Quick Facts
- NPI
- 1619091618
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile